blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2090579

EP2090579 - Substituted heteroarylamide diazepinopyrimidone derivatives [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.12.2010
Database last updated on 31.08.2024
Most recent event   Tooltip10.12.2010Application deemed to be withdrawnpublished on 12.01.2011  [2011/02]
Applicant(s)For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-shi
Osaka 541-8505 / JP
[N/P]
Former [2010/01]For all designated states
Sanofi-Aventis
174 Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-Shi
Osaka 541-8505 / JP
Former [2009/34]For all designated states
Sanofi-Aventis
174 Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Inventor(s)01 / Fayol, Aude
sanofi-aventis Dépt Brevets 174 avenue de France
75013 Paris / FR
02 / Lochead, Alistair
sanofi-aventis Dépt Brevets 174 avenue de France
75013 Paris / FR
03 / Saady, Mourad
sanofi-aventis Dépt Brevets 174 avenue de France
75013 Paris / FR
04 / Vache, Julien
sanofi-aventis Dépt Brevets 174 avenue de France
75013 Paris / FR
05 / Yaiche, Philippe
sanofi-aventis Dépt Brevets 174 avenue de France
75013 Paris / FR
 [2009/34]
Representative(s)Morel-Pécheux, Muriel, et al
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
[N/P]
Former [2009/34]Morel-Pécheux, Muriel, et al
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
Application number, filing date08290076.229.01.2008
[2009/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2090579
Date:19.08.2009
Language:EN
[2009/34]
Search report(s)(Supplementary) European search report - dispatched on:EP21.07.2008
ClassificationIPC:C07D487/04, C07D403/04, A61K31/519
[2009/34]
CPC:
C07D487/04 (EP,US); A61P13/12 (EP); A61P17/00 (EP);
A61P17/14 (EP); A61P19/00 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P21/00 (EP); A61P21/02 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P33/06 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D519/00 (EP,US) (-)
Designated contracting statesFR [2010/17]
Former [2009/34]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Substituierte Heteroarylamiddiazepinopyrimidon-Derivate[2009/34]
English:Substituted heteroarylamide diazepinopyrimidone derivatives[2009/34]
French:Dérivés d'hétéroarylamide diazépinopyrimidone substitués[2009/34]
Examination procedure19.02.2010Examination requested  [2010/13]
20.02.2010Loss of particular rights, legal effect: designated state(s)
15.03.2010Despatch of a communication from the examining division (Time limit: M04)
26.03.2010Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
27.07.2010Application deemed to be withdrawn, date of legal effect  [2011/02]
27.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/02]
Fees paidRenewal fee
13.01.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP1557417  (SANOFI AVENTIS [FR], et al) [A] 1-17 * the whole document *;
 [A]EP1790649  (SANOFI AVENTIS [FR], et al) [A] 1-17 * the whole document *;
 [A]  - ROBERT M KYPTA, "GSK-3 inhibitors and their potential in the treatment of Alzheimer's disease", EXPERT OPINION ON THERAPEUTICAL PATENTS, (2005), vol. 15, no. 10, pages 1315 - 1331, XP002486909 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.15.10.1315
by applicantDE2705582
 WO9716430
    - NATURE, (200406), vol. 3, pages 479 - 487
    - TRENDS IN PHARMACOLOGICAL SCIENCES, (20040909), vol. 25, pages 471 - 480
    - JOURNAL OF NEUROCHEMISTRY, (2004), vol. 89, pages 1313 - 1317
    - MEDICINAL RESEARCH REVIEWS, (2002), vol. 22, no. 4, pages 373 - 384
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2002), vol. 277, no. 37, pages 33791 - 33798
    - BIOCHEM. J., (2003), vol. 372, pages 129 - 136
    - EUROPEAN JOURNAL OF NEUROSCIENCE, (2005), vol. 22, pages 301 - 309
    - NATURE MEDICINE, (2004), vol. 10, pages 55 - 63
    - BIOCHIMICA ET BIOPHYSICAACTA, (2004), vol. 1697, pages 181 - 196
    - J. BIOL. CHEM., (2008), vol. 283, pages 358 - 366
    - TETRAHEDRON LETTERS, (1989), vol. 30, no. 45, pages 6113 - 6116
    - TETRAHEDRON LETTERS, vol. 32, no. 22, pages 2469 - 2470
    - WOODGETT, J. R., ANALYTICAL BIOCHEMISTRY, (1989), vol. 180, pages 237 - 241
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.